Nicotinamide phosphoribosyltransferase pseudogene 3 (NAMPTP3)

Nicotinamide phosphoribosyltransferase pseudogene 3 (NAMPTP3) is classified as a pseudogene, meaning it is a segment of DNA that resembles a protein-coding gene (in this case, NAMPT) but typically does not code for a functional protein. Pseudogenes can be transcribed into non-coding RNAs or produce small RNAs that may have regulatory roles in gene expression, often acting as competitive endogenous RNAs (ceRNAs) or participating in epigenetic regulation[1][2]. However, there is no specific evidence indicating that NAMPTP3 itself is disease-relevant or has direct functional roles in cellular processes. It is not considered a therapeutic target, and no drugs are known to interact with it. “NAMPTP3” is therefore not a target of pharmacological interest and is most often included in genomic studies for annotation purposes only. Summary of correctness: - This entry is not a functional drug target or molecule. - The naming is correct for a pseudogene, but it is not an active molecule for drug discovery. - It should not be included in lists of actionable or protein-coding targets under conventional drug discovery paradigms[2][3].

Other names

NAMPT pseudogene 3NAMPTP3

None established for drugs (typical for pseudogenes)